Skip to content
Search

Latest Stories

Pharmacies reminded to submit Covid-19 test distribution data to avoid order ban

The Pharmaceutical Services Negotiating Committe (PSNC) has reminded contractors to submit Covid-19 test distribution service weekly data to help Department of Health and Social Care (DHSC) to monitor the stock availability.

"If pharmacies are not routinely reporting the distribution of test kits to the public, but are still ordering test kits from the wholesaler, this may be viewed as an accumulation of test kits," said PSNC.


The agency added that the DHSC may request Alliance Healthcare Distribution to block further orders for test kits from these pharmacies.

"These order bars may then not be lifted until reported distribution from the pharmacy via MYS indicates more regular use of the service at the pharmacy and a reduced level of test kits stock held in the pharmacy," it noted.

The contractors who have signed up to provide the NHS community Pharmacy Covid-19 Lateral Flow Device Distribution Service need to record the information on the NHSBSA Manage Your Service (MYS) portal by close of business on the pharmacy’s last trading day of the week.

When contractors receive test kits from the wholesaler, information such as Lot Number, quantity of cartons, supplying wholesaler, and date of receipt must be entered on the MYS portal by close of business on the pharmacy’s last trading day of the week

Contractors can use PSNC's Covid-19 Lateral Flow Device Stock Record Sheet (available in PDF or Microsoft Word) to record this information.

They are also required to keep the above information for six months to support product recalls on the test kits. 

With regards to contractors' supply test kits, they are expected to ask three questions and the answers to two of the questions must be entered into the MYS portal by the close of business on the pharmacy’s last trading day of the week. 

PSNC has produced data collection sheets which contractors can use to record the answers to these questions (PDF or Microsoft Word); this information can then to be added to the MYS portal at a later date/time in the week. 

These are requirements of the service specification and assist the DHSC with weekly activity reporting to the government, as well as supporting DHSC with regular monitoring of test kit stock availability. 

More For You

GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less
Community Pharmacy Scotland secures £10m reimbursement uplift amid ongoing negotiations

Negotiations continue on the Global Sum element of remuneration.

Getty Images

Community Pharmacy Scotland secures £120m reimbursement deal for 2025/26

Community Pharmacy Scotland (CPS) has accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

The agreement marks the first phase of ongoing negotiations surrounding community pharmacy funding for the upcoming financial year.

Keep ReadingShow less